US Stock MarketDetailed Quotes

BBLG Bone Biologics

Watchlist
  • 1.1999
  • +0.0899+8.10%
Close Jul 22 16:00 ET
1.32MMarket Cap0.06P/E (TTM)

Bone Biologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
3.45%-1.3M
-167.90%-9.56M
-3.45%-2.02M
-546.44%-2.56M
-908.90%-3.63M
-56.83%-1.35M
-190.33%-3.57M
-944.03%-1.95M
-42.30%-395.28K
43.38%-360.06K
Net income from continuing operations
76.66%-865.97K
-502.76%-8.95M
-273.47%-1.55M
-57.45%-1.92M
-276.99%-1.77M
-438.06%-3.71M
7.83%-1.48M
602.69%893.46K
-139.40%-1.22M
4.59%-469.3K
Operating gains losses
-106.63%-37.31K
69.35%-892.69K
---24.76K
---160.65K
---1.27M
--562.92K
---2.91M
----
----
----
Other non cash items
----
----
----
----
----
---1
47.66%731.71K
----
----
----
Change In working capital
-125.84%-452.81K
178.94%132.92K
29.15%-514.51K
-162.53%-494.89K
-773.99%-609.9K
640.60%1.75M
47.46%-168.37K
-1,023.30%-726.21K
1,749.54%791.46K
122.39%90.49K
-Change in prepaid assets
-72.54%99.25K
125.68%245.73K
77.01%-187.44K
46.08%91.48K
-126.49%-19.8K
229.51%361.49K
---956.93K
-1,763.01%-815.19K
227.76%62.63K
--74.77K
-Change in payables and accrued expense
-1,426.51%-552.07K
13,655.69%670.87K
165.73%456.61K
-180.45%-586.37K
4,727.42%759.02K
192.49%41.62K
101.33%4.88K
-2,444.23%-694.69K
5,320.16%728.84K
103.75%15.72K
-Change in other working capital
----
-200.00%-783.68K
----
----
----
--1.35M
1,641.50%783.68K
----
----
----
Cash from discontinued investing activities
Operating cash flow
3.45%-1.3M
-167.90%-9.56M
-3.45%-2.02M
-546.44%-2.56M
-908.90%-3.63M
-56.83%-1.35M
-190.33%-3.57M
-944.03%-1.95M
-42.30%-395.28K
43.38%-360.06K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
1.5M
13.87%5.04M
-86.64%592K
0
4.45M
0
-43.95%4.43M
-35.41%4.43M
0
Net common stock issuance
--1.5M
13.87%5.04M
-86.64%592K
--0
--4.45M
--0
-35.41%4.43M
--4.43M
--0
----
Cash from discontinued financing activities
Financing cash flow
--1.5M
13.87%5.04M
-86.64%592K
--0
--4.45M
--0
-43.95%4.43M
-35.41%4.43M
--0
----
Net cash flow
Beginning cash position
-59.85%3.03M
12.93%7.54M
-11.99%4.45M
28.48%7.01M
6.43%6.19M
12.93%7.54M
--6.68M
149,847.93%5.06M
122,804.96%5.45M
8,070.57%5.81M
Current changes in cash
114.89%201.07K
-622.83%-4.51M
-157.52%-1.43M
-546.44%-2.56M
327.60%819.49K
-56.83%-1.35M
-87.07%862.95K
-62.84%2.48M
-37,050.28%-395.28K
-439.61%-360.06K
End cash Position
-47.84%3.23M
-59.85%3.03M
-59.85%3.03M
-11.99%4.45M
28.48%7.01M
6.43%6.19M
12.93%7.54M
12.93%7.54M
149,847.93%5.06M
122,804.96%5.45M
Free cash flow
3.45%-1.3M
-167.90%-9.56M
-3.45%-2.02M
-546.44%-2.56M
-908.90%-3.63M
-56.83%-1.35M
-190.33%-3.57M
-944.03%-1.95M
-42.30%-395.28K
43.38%-360.06K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 3.45%-1.3M-167.90%-9.56M-3.45%-2.02M-546.44%-2.56M-908.90%-3.63M-56.83%-1.35M-190.33%-3.57M-944.03%-1.95M-42.30%-395.28K43.38%-360.06K
Net income from continuing operations 76.66%-865.97K-502.76%-8.95M-273.47%-1.55M-57.45%-1.92M-276.99%-1.77M-438.06%-3.71M7.83%-1.48M602.69%893.46K-139.40%-1.22M4.59%-469.3K
Operating gains losses -106.63%-37.31K69.35%-892.69K---24.76K---160.65K---1.27M--562.92K---2.91M------------
Other non cash items -----------------------147.66%731.71K------------
Change In working capital -125.84%-452.81K178.94%132.92K29.15%-514.51K-162.53%-494.89K-773.99%-609.9K640.60%1.75M47.46%-168.37K-1,023.30%-726.21K1,749.54%791.46K122.39%90.49K
-Change in prepaid assets -72.54%99.25K125.68%245.73K77.01%-187.44K46.08%91.48K-126.49%-19.8K229.51%361.49K---956.93K-1,763.01%-815.19K227.76%62.63K--74.77K
-Change in payables and accrued expense -1,426.51%-552.07K13,655.69%670.87K165.73%456.61K-180.45%-586.37K4,727.42%759.02K192.49%41.62K101.33%4.88K-2,444.23%-694.69K5,320.16%728.84K103.75%15.72K
-Change in other working capital -----200.00%-783.68K--------------1.35M1,641.50%783.68K------------
Cash from discontinued investing activities
Operating cash flow 3.45%-1.3M-167.90%-9.56M-3.45%-2.02M-546.44%-2.56M-908.90%-3.63M-56.83%-1.35M-190.33%-3.57M-944.03%-1.95M-42.30%-395.28K43.38%-360.06K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 1.5M13.87%5.04M-86.64%592K04.45M0-43.95%4.43M-35.41%4.43M0
Net common stock issuance --1.5M13.87%5.04M-86.64%592K--0--4.45M--0-35.41%4.43M--4.43M--0----
Cash from discontinued financing activities
Financing cash flow --1.5M13.87%5.04M-86.64%592K--0--4.45M--0-43.95%4.43M-35.41%4.43M--0----
Net cash flow
Beginning cash position -59.85%3.03M12.93%7.54M-11.99%4.45M28.48%7.01M6.43%6.19M12.93%7.54M--6.68M149,847.93%5.06M122,804.96%5.45M8,070.57%5.81M
Current changes in cash 114.89%201.07K-622.83%-4.51M-157.52%-1.43M-546.44%-2.56M327.60%819.49K-56.83%-1.35M-87.07%862.95K-62.84%2.48M-37,050.28%-395.28K-439.61%-360.06K
End cash Position -47.84%3.23M-59.85%3.03M-59.85%3.03M-11.99%4.45M28.48%7.01M6.43%6.19M12.93%7.54M12.93%7.54M149,847.93%5.06M122,804.96%5.45M
Free cash flow 3.45%-1.3M-167.90%-9.56M-3.45%-2.02M-546.44%-2.56M-908.90%-3.63M-56.83%-1.35M-190.33%-3.57M-944.03%-1.95M-42.30%-395.28K43.38%-360.06K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg